It isn't all about size and near-term EPS accretion, said Deutsche Bank analyst Gregg Gilbert, speaking in regard to Teva ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS View Hot Comments Rumors